Journal article
Hangzhou criteria as downstaging criteria in hepatocellular carcinoma before liver transplantation: A multicenter study from China
Abstract
BACKGROUND: The downstaging of hepatocellular carcinoma (HCC) has been confirmed to benefit liver transplantation (LT) patients whose tumors are beyond the transplantation criteria. Milan criteria (MC), a tumor size and number-based assessment, is currently used as the endpoint in these patients. However, many studies believe that tumor biological behavior should be added to the evaluation criteria for downstaging efficacy. Hence, this study …
Authors
Zhan Q-F; Ling S-B; Deng Y-N; Shan Q-N; Ye Q-W; Xu S-J; Jiang G-J; Lu D; Wei X-Y; Zhuang L
Journal
Hepatobiliary & Pancreatic Diseases International, Vol. 19, No. 4, pp. 349–357
Publisher
Elsevier
Publication Date
August 2020
DOI
10.1016/j.hbpd.2020.06.011
ISSN
1499-3872